3002
D. Crich, D. Grant / Tetrahedron Letters 49 (2008) 2999–3003
62.5, 98.5, 124.1, 124.7, 126.8, 127.1, 127.8, 128.1, 128.3, 128.65,
O
S
N
N
SO2Ph
128.74, 130.0, 130.2, 130.9, 133.1, 133.3, 138.4, 139.5, 140.4; Anal.
Calcd for C21H17IN2O2S: C, 51.65; H, 3.51. Found: C, 51.83; H, 3.61.
1-(2-Iodobenzyl)-2-(2-naphthylmethyl sulfonyl)benzimidazole (13) a
white solid. Mp 148–150 °C, 1H NMR (500 MHz, CDCl3): 4.99 (s,
2H), 5.05 (s, 2H), 5.92 (d, J = 8.0 Hz, 1H), 6.61 (t, J = 7.5 Hz, 1H),
6.78 (t, J = 7.5 Hz, 1H), 6.96 (d, J = 8.5 Hz, 1H), 7.25 (dd,J = 2.0,
8.0 Hz, 1H), 7.33 (dt, J = 1.0, 8.0 Hz, 1H), 7.41–7.48 (m, 2H), 7.51 (t,
J = 1.0, 7.5 Hz, 1H), 7.64 (d, J = 7.5 Hz, 1H), 7.70–7.74 (m, 3H), 7.82
(d, J = 8.0 Hz, 1H), 8.00–8.03 (m, 1H).
1) 25, Cs2CO3,
DMF, rt
Br
N
O
N
SO2Ph
2) ammonium
heptamolybdate
H2O2 30% in H2O
92% two steps
37
I
38
O
N
S
SO2Ph
N
N
O
+
Bu3SnH, AIBN
5 hr, addition
N
9. Orth, R. E. J. Pharm. Sci. 1963, 52, 909–910.
SO2Ph
toluene, Δ
10. Lieber, E.; Chao, T. S.; Rao, C. N. R. Can J. Chem. 1959, 37, 118–
119.
39
42%
40
26%
11. 1-(2-Iodobenzyl)-5-thiotetrazole (17). Sodium azide (325 mg, 5.0
mmol) and 16 (0.9 g, 3.3 mmol) were dissolved in water (10 mL)
and DMF (5 mL). The reaction mixture was heated to 100 °C for
24 h, at which point it was then acidified to pH 5 and extracted with
EtOAc (3 ꢀ 25 mL), the organic layer was washed with brine and
dried with Na2SO4. The solvent was removed in vacuo and the residue
was purified by silica gel column chromatography (eluent: 50% to neat
Scheme 5. Alkyl radical generation via sulfone 38.
sulfone can then be used to generate the corresponding
alkyl radical under typical AIBN/tributyltin hydride medi-
ated conditions.
1
EtOAc in hexanes) to afford 17 (250 mg, 0.79 mmol, 24%). H NMR
(500 MHz, CD3OD): 5.48 (s, 2H), 7.07 (dt, J = 1.5, 7.5 Hz, 1H), 7.71
(dd, J = 1.5, 7.5 Hz, 1H), 7.36 (dt, J = 1.5, 8.0 Hz, 1H), 7.93 (dd,
J = 1.5, 8.0 Hz, 1H); 13C NMR (125 MHz, CD3OD): 54.4, 99.6,
128.4, 128.9, 129.7, 136.8, 139.6, 145.0. 1-(2-Iodobenzyl)-5-(naph-
References and notes
1. Crich, D.; Hutton, T. K.; Ranganathan, K. J. Org. Chem. 2005, 70,
7672–7678.
2. Loven, R.; Speckamp, W. N. Tetrahedron Lett. 1972, 16, 1567–1570.
3. Caddick, S.; Aboutayab, K.; West, R. Synlett 1993, 231–232.
4. Caddick, S.; Aboutayab, K.; West, R. I. J. Chem. Soc., Chem.
Commun. 1995, 1353–1354.
5. Aldabbagh, F.; Bowman, W. R.; Mann, E. Tetrahedron Lett. 1997,
38, 7937–7940.
6. Aldabbagh, F.; Bowman, W. R. Tetrahedron 1999, 55, 4109–4122.
7. Chatgilialoglu, C.; Lunazzi, L.; Ingold, K. U. J. Org. Chem. 1983, 48,
3588–3589.
thylmethylthio)tetrazole (18). To
a solution of 17 (200 mg,
0.629 mmol), Et3N (135 lL, 0.950 mmol) and DMAP (5 mg) was
added 2-bromomethyl naphthalene (153 mg, 692 lmol). The reaction
mixture was kept stirring at rt for 3 h before the solvent was removed
in vacuo. The residue was partitioned between EtOAc and satd
NaHCO3 (25 mL each), the organic layer was then evaporated and
the residue was purified by silica gel column chromatography to
afford the title compound 18 (286 mg, 0.629 mmol, quant. yield) as a
1
colorless oil. H NMR (500 MHz, CDCl3): 4.67 (s, 2H), 5.31 (s, 2H),
6.62 (dd, J = 1.5, 7.5 Hz, 1H), 6.94 (dt, J = 1.5, 7.5 Hz, 1H), 7.09 (dt,
J = 1.5, 7.5 Hz, 1H), 7.43 (dd, J = 2.0, 8.0 Hz, 1H), 7.45–7.48 (m,
2H), 7.75–7.80 (m, 5H); 13C NMR (125 MHz, CDCl3): 38.4, 55.4,
97.9, 126.5, 126.6, 126.7, 127.7, 128.0, 128.3, 128.6, 128.8, 130.4,
132.9, 133.0, 133.2, 135.4, 139.8, 154.1; EI-HRMS calcd [M]+:
458.00621, found: 458.00710. 1-(2-Iodobenzyl)-5-(naphthylmethyl-
sulfonyl)tetrazole (19). Ammonium heptamolybdate (75 mg) and 18
(250 mg, 0.545 mmol) were taken up in EtOH (5 mL) and H2O2 (30%
in water, 1 mL) was added. The reaction mixture was kept stirring for
24 h before being filtered through a plug of silica (eluent: EtOAc),
evaporation of the solvent in vacuo afforded the title compound 19.
(225 mg, 0.46 mmol, 84%). 1H NMR (500 MHz, CDCl3): 5.00 (s, 2H),
5.36 (s, 2H), 6.26 (d, J = 7.5 Hz, 1H), 6.81 (t, J = 7.5 Hz, 1H), 6.88 (t,
J = 7.5 Hz, 1H), 7.33 (d, J = 8.0 Hz, 1H), 7.52–7.58 (m, 2H), 7.71–
7.85 (m, 5H); 13C NMR (125 MHz, CDCl3): 57.3, 62.8, 98.2, 122.2,
127.1, 127.6, 127.8, 128.3, 128.4. 128.6, 129.2, 130.4, 131.6, 133.1,
133.5, 135.0, 139.8, 152.2.
8. General synthesis of compounds 9, 11, and 13. To a solution of 2-thio
imidazole/phenol (2.0 mmol) and 2-(bromomethyl)naphthalene
(486 mg, 2.2 mmol) dissolved in DCM (10 mL) and CH3CN (5 mL)
were added Et3N (3.0 mmol) and DMAP (5 mg). The reaction
mixture was stirred 2 h at rt, the solvent was then removed in vacuo
and the residue was taken up in DCM (25 mL) and washed with water
(2 ꢀ 25 mL) the organic layer was concentrated in vacuo and the
residue was purified by silica gel column chromatography. A solution
of the resulting thioether (1.17 mmol) and 2-iodobenzyl bromide
(1.4 mmol) in DMF (10 mL) was treated with K2CO3 (1.75 mmol).
The reaction mixture was stirred at rt for 14 h before it was
partitioned between EtOAc (25 mL) and water (30 mL), the organic
layer was then washed with brine and dried with Na2SO4. The solvent
was removed in vacuo and the residue was purified by silica gel
chromatography. Oxidation of the resulting thioether (1.25 mmol)
was undertaken with catalytic ammonium heptamolybdate (154 mg,
10 mol %) in EtOH (5 mL). To this solution was added H2O2 (30% in
water, 2.0 mL); after stirring for 14 h the reaction mixture was
partitioned between water (20 mL) and EtOAc (20 mL), the organic
layer was evaporated and the residue was purified by silica gel column
chromatography. 2-[20-(2-Iodobenzyloxy)phenylsulfonylmethyl]naph-
thalene (9) as a white solid, mp 147–149 °C, 1H NMR (500 MHz,
CDCl3): 4.75 (s, 2H), 5.30 (s, 2H), 6.99 (t, J = 7.5 Hz, 1H), 7.27 (dd,
J = 1.5, 8.5 Hz, 1H), 7.43–7.47 (m, 2H), 7.51 (t, J = 8.0 Hz, 1H), 7.56
(dt, J = 1.5, 7.5 Hz, 1H), 7.63 (s, 1H), 7.69–7.78 (m, 4H), 7.89–7.92
(m, 2H); 13C NMR (125 MHz, CDCl3): 60.9, 75.2, 96.9, 113.6, 121.4,
125.5, 126.3, 126.5, 126.8, 127.7, 127.9, 128.3, 129.0, 129.2, 130.1,
130.6, 131.4, 133.1, 135.7, 137.9, 139.3, 156.2. 1-(2-Iodobenzyl)-2-
(naphthylmethylsulfonyl)imidazole (11) as a white solid 1H NMR
(500 MHz, CDCl3): 4.67 (s, 2H), 4.75 (s, 2H), 6.15 (s, 1H), 6.60 (s,
1H), 6.79 (s, 2H), 7.21–7.25 (m, 1H), 7.25 (s, 1H), 7.74–7.51 (m, 2H),
7.52 (s, 1H), 7.64–7.83 (m, 4H); 13C NMR (125 MHz, CDCl3): 55.4,
12. Blakemore, P. R.; Cole, W. J.; Kochienski, P. J.; Morley, A. Synlett
1998, 26–28.
13. Karady, S.; Abramson, N. L.; Dolling, U.-H.; Douglas, A. W.;
McManemin, G. J.; Marcune, B. J. Am. Chem. Soc. 1995, 117, 5425–
5426.
14. Karady, S.; Cummins, J. M.; Dannenberg, J. J.; del Rio, E.; Dormer,
P. G.; Marcune, B. F.; Reamer, R. A.; Sordo, T. L. Org. Lett. 2003, 5,
1175–1178.
15. Cummins, J. M.; Dolling, U.-H.; Douglas, A. W.; Karady, S.;
Leonard, W. R.; Marcune, B. F. Tetrahedron Lett. 1999, 40, 6153–
6156.
16. Allin, S. M.; Bowman, W. R.; Karim, R.; Rahman, S. S. Tetrahedron
2006, 62, 4306–4316.
17. 1-(2-Iodobenzyl)-2-thiobenzimidazole (25). Compound 24 (3.4 g,
9.2 mmol) was dissolved in EtOH (30 mL) and THF (10 mL), to this
solution was added KSAc (1.27 g, 11.1 mmol). The reaction mixture
was heated to 70 °C and stirred for 24 h, at which point TLC